Hyperosmolar composition of hyaluronic acid
AssigneeHorus Pharma
InventorsJean-François Rouland, Martine Claret, Claude Claret
Life of this patent
Estimating the term…
Abstract
The invention relates to a novel hyperosmolar composition of hyaluronic acid for the use thereof in the treatment of conical oedema.
Claims15
A hyperosmolar ophthalmic composition comprising 0.01 to 0.2% by weight of sodium hyaluronate, 0.05 to 0.5% by weight of hydroxypropylmethyl cellulose and sodium chloride as a hyperosmolarity agent, wherein the hyperosmolar ophthalmic composition has an osmolarity of 1500 to 2000 mOsm/l and a viscosity of 15 to 100 centipoises.
A hyperosmolar ophthalmic composition having an osmolarity of 1500 to 2000 mOsm/l, and comprising 4 to 6% by weight of the composition of sodium chloride as hyperosmolarity agent, 0.01 to 0.25% by weight of sodium hyaluronate and 0.05 to 0.5% by weight of hydroxypropylmethyl cellulose.
Dependencies are inferred from the claim text.